NCT06363578View on ClinicalTrials.gov

Different Doses of Dexmedetomidine in External Oblique Intercostal Plane Block in Splenectomy

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

March 8, 2025

Study Completion Date

March 8, 2025

Conditions
DexmedetomidineExternal Oblique Intercostal Plane BlockSplenectomy
Interventions
DRUG

Dexmedetomidine 0.5 μg/kg

Patients will receive 29 ml bupivacaine 0.25% + 1 ml dexmedetomidine 0.5 μg/kg diluted in saline.

DRUG

Dexmedetomidine 1 μg/kg

Patients will receive 29 ml bupivacaine 0.25% + 1 ml dexmedetomidine 1 μg/kg diluted in saline.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06363578 - Different Doses of Dexmedetomidine in External Oblique Intercostal Plane Block in Splenectomy | Biotech Hunter | Biotech Hunter